CenterBook Partners LP Acquires Shares of 3,046 Addus HomeCare Corporation (NASDAQ:ADUS)

CenterBook Partners LP bought a new stake in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 3,046 shares of the company's stock, valued at approximately $301,000.

Other hedge funds have also made changes to their positions in the company. Alliancebernstein L.P. grew its holdings in Addus HomeCare by 0.5% during the 4th quarter. Alliancebernstein L.P. now owns 19,661 shares of the company's stock worth $2,465,000 after acquiring an additional 91 shares during the period. Natixis lifted its position in Addus HomeCare by 111.9% during the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after buying an additional 132 shares in the last quarter. Heritage Family Offices LLP lifted its position in Addus HomeCare by 6.3% during the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after buying an additional 143 shares in the last quarter. Hohimer Wealth Management LLC lifted its position in Addus HomeCare by 6.3% during the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after buying an additional 152 shares in the last quarter. Finally, Stifel Financial Corp lifted its position in Addus HomeCare by 1.2% during the 4th quarter. Stifel Financial Corp now owns 12,794 shares of the company's stock worth $1,604,000 after buying an additional 153 shares in the last quarter. Institutional investors own 95.35% of the company's stock.

Insider Activity at Addus HomeCare

In other news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction that occurred on Tuesday, May 27th. The shares were sold at an average price of $115.00, for a total transaction of $235,175.00. Following the transaction, the executive vice president directly owned 7,796 shares in the company, valued at approximately $896,540. This trade represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 4.60% of the company's stock.

Addus HomeCare Stock Performance

Shares of ADUS stock traded up $1.37 during mid-day trading on Monday, reaching $108.40. 31,128 shares of the company's stock traded hands, compared to its average volume of 165,873. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72. The firm has a 50 day moving average price of $112.44 and a two-hundred day moving average price of $109.81. The firm has a market capitalization of $1.99 billion, a PE ratio of 24.50, a price-to-earnings-growth ratio of 1.52 and a beta of 0.81.

Addus HomeCare (NASDAQ:ADUS - Get Free Report) last released its earnings results on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.33 by $0.09. The firm had revenue of $337.71 million during the quarter, compared to analysts' expectations of $341.66 million. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The firm's revenue was up 20.3% on a year-over-year basis. During the same quarter last year, the business posted $1.21 earnings per share. On average, research analysts forecast that Addus HomeCare Corporation will post 4.59 EPS for the current year.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on the stock. JMP Securities reissued a "market outperform" rating and issued a $150.00 price target on shares of Addus HomeCare in a report on Wednesday, July 16th. Macquarie reaffirmed an "outperform" rating and set a $133.00 target price on shares of Addus HomeCare in a report on Tuesday, June 10th. Finally, Wall Street Zen raised shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Seven investment analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus price target of $142.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.